The definition with no lean patient in it

A study in Diabetologia, run by Amsterdam University Medical Centers with the University of Ghana, covered adults with type 2 diabetes in Ghana, Nigeria, Kenya and Europe. In wealthy countries 9 of 10 people with the disease carry extra weight. In Africa nearly 4 of 10 do not, and in rural Ghana 6 of 10 are lean. The researchers place roughly 10 million people across the continent outside the pattern the textbooks describe.[1]

The difference goes deeper than body shape. Lean patients fall ill because the pancreas does not make enough insulin; heavier patients because the body resists the insulin it has. The complications diverge with it: retinopathy and strokes were more common among the lean, hypertension and cardiovascular risk among the overweight, while chronic kidney disease landed on both groups at similar rates. Its authors ask for trials aimed squarely at lean patients.[1]

The same gap, counted in blood

In the Canadian Medical Association Journal, 42 Black adults in Canada describe why they do not donate blood. They name the country's malaria-related deferral rules, stricter than those in other G7 countries such as the United States and France; a mistrust of donation systems built on their own experiences with health care institutions; a sense of being devalued that they tie to anti-Black racism; and the low confidence those experiences leave behind. 57 per cent of the participants identified as women, and most held a university degree.[2]

Sickle cell disease asks for red cells closely matched to the patient, and matching holds best within the same ancestry, so the donor shortfall shows up at a bedside. Read beside the Ghanaian figures, the two shortfalls share a shape: a clinical system calibrated on the population it saw most often, and a cost that settles on the people it saw least. The competing reading deserves to stay open — a research funding gap in one case and a recruitment failure in the other could be separate problems that merely resemble each other.[1], [2]

The step that would move it

In August this column read Europe's summer through the heat itself and the uneven capacity to withstand it. A clinical category behaves the same way: a fact about bodies and, at the same time, a description of whose body was measured. The next step is narrow enough to check. If the call in Diabetologia is taken up, trial registries should show recruitment specifically in lean African cohorts within the next two years; without it, 10 million patients stay outside the evidence base that decides their treatment.[1], [3]